Mohammadreza Nikmaneshi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Biological | 5 | 2024 | 9443 | 0.720 |
Why?
|
| Neovascularization, Pathologic | 4 | 2024 | 2631 | 0.660 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3946 | 0.610 |
Why?
|
| Neoplasms | 8 | 2024 | 22340 | 0.610 |
Why?
|
| Models, Cardiovascular | 2 | 2021 | 978 | 0.600 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2023 | 2056 | 0.570 |
Why?
|
| Cytosol | 2 | 2017 | 885 | 0.560 |
Why?
|
| Pseudopodia | 1 | 2017 | 168 | 0.550 |
Why?
|
| Myosins | 1 | 2017 | 408 | 0.510 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13648 | 0.480 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 540 | 0.480 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 687 | 0.420 |
Why?
|
| Actins | 2 | 2017 | 2056 | 0.420 |
Why?
|
| Mathematical Concepts | 2 | 2024 | 77 | 0.350 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2207 | 0.340 |
Why?
|
| Cell Movement | 2 | 2017 | 5194 | 0.280 |
Why?
|
| Systems Biology | 2 | 2021 | 481 | 0.270 |
Why?
|
| Models, Theoretical | 4 | 2024 | 3564 | 0.270 |
Why?
|
| Liver | 1 | 2020 | 7562 | 0.230 |
Why?
|
| Computer Simulation | 4 | 2024 | 6255 | 0.170 |
Why?
|
| Models, Immunological | 1 | 2022 | 517 | 0.160 |
Why?
|
| Ammonia | 1 | 2020 | 244 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 379 | 0.160 |
Why?
|
| Monte Carlo Method | 1 | 2024 | 1238 | 0.160 |
Why?
|
| Cichlids | 1 | 2017 | 9 | 0.150 |
Why?
|
| Goldfish | 1 | 2017 | 65 | 0.150 |
Why?
|
| Urea | 1 | 2020 | 448 | 0.150 |
Why?
|
| Albumins | 1 | 2020 | 577 | 0.140 |
Why?
|
| Immunotherapy | 2 | 2023 | 4752 | 0.140 |
Why?
|
| Shear Strength | 1 | 2017 | 160 | 0.140 |
Why?
|
| Actomyosin | 1 | 2017 | 112 | 0.140 |
Why?
|
| Porosity | 1 | 2017 | 347 | 0.140 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2020 | 345 | 0.130 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 2002 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2020 | 1137 | 0.120 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 578 | 0.120 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 626 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 1084 | 0.120 |
Why?
|
| Viral Load | 1 | 2024 | 3386 | 0.120 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 643 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 800 | 0.110 |
Why?
|
| Rheology | 1 | 2015 | 348 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2020 | 1113 | 0.110 |
Why?
|
| Species Specificity | 1 | 2017 | 2406 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2020 | 1247 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2017 | 1500 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 1668 | 0.100 |
Why?
|
| Algorithms | 2 | 2024 | 14071 | 0.100 |
Why?
|
| Coronary Vessels | 2 | 2020 | 3096 | 0.090 |
Why?
|
| Cell Survival | 1 | 2020 | 5747 | 0.080 |
Why?
|
| Disease Progression | 3 | 2021 | 13632 | 0.080 |
Why?
|
| Humans | 15 | 2024 | 765968 | 0.080 |
Why?
|
| Oxygen | 1 | 2020 | 4241 | 0.070 |
Why?
|
| Glucose | 1 | 2020 | 4335 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10261 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20124 | 0.060 |
Why?
|
| Animals | 5 | 2024 | 168764 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2024 | 3081 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 734 | 0.040 |
Why?
|
| Hypertension | 1 | 2017 | 8626 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 3513 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 2010 | 0.030 |
Why?
|
| Vaccination | 1 | 2024 | 3426 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3211 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2017 | 4184 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 8041 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7421 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5337 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17075 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15398 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9249 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16721 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15880 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 81819 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 171117 | 0.000 |
Why?
|
| Male | 1 | 2022 | 363698 | 0.000 |
Why?
|
| Female | 1 | 2022 | 396112 | 0.000 |
Why?
|